Trade Summary

1 week ago, Lerner Neil, serving as CHIEF ACCOUNTING OFFICER at Compass Therapeutics, Inc. (CMPX), purchased 15,000 shares at $1.89 per share, for a total transaction value of $28,350.00. Following this transaction, Lerner Neil now holds 397,500 shares of CMPX.

This purchase represents a 4.00% increase in Lerner Neil's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, April 29, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 30, 2026, 1 day after the trade was made.

Compass Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.